Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Montreux Equity Partners

1.EuclidSR - Press Room   (65%):
back to news index SkinMedica Closes $15 million Round of Financing 04/05/2005 April 5, 2005 - SkinMedica, Inc., a specialty pharmaceutical company developing and marketing dermatology products, announced today the closing of a $15 million private placement of its Series E preferred stock. EuclidSR...
2.EuclidSR - Press Room   (65%):
back to news index SkinMedica Closes $15 million Round of Financing 04/05/2005 April 5, 2005 - SkinMedica, Inc., a specialty pharmaceutical company developing and marketing dermatology products, announced today the closing of a $15 million private placement of its Series E preferred stock. EuclidSR...
3.Arboretum Ventures: Portfolio   (63%):
Asterand, Inc operates one of the world s largest tissue banks for genomic and proteomic research. Co-Investors: Oxford Bioscience Partners, Fort Washington Capital Partners, Chrysalis Ventures, Apjohn Ventures CardioMEMS, Inc. is creating innovative devices for the diagnosis, treatment and managem...
4.BA Venture Partners - News: Portfolio News   (55%):
BAVP News Portfolio News Events Somaxon Files IPO To Raise Up To $86.25M In Common Stock By VentureWire Staff Reporters VenutreWire: October 10th, 2005 Psychiatric drug developer Somaxon Pharmaceuticals Inc. Friday filed for an initial public offering to sell up to $86.25 million in common stock, in...
5.Vivo Ventures: News & Events   (48%):
News & Events Avera Pharmaceuticals Raises $48 million in Series C Venture Financing; New Board Members Named SAN DIEGO - August 4, 2004 -- Avera Pharmaceuticals, Inc., a privately held pharmaceutical development company focused on medicines for psychiatric and neurologic illnesses, today announ...
6.H.I.G. Capital: News   (48%):
FOR IMMEDIATE RELEASE Aaron Davidson Managing Director H.I.G. Ventures, LLC (305) 379-2322 Avera Pharmaceuticals Raises $48 million in Series C Venture Financing; New Board Members Named SAN DIEGO - August 4, 2004 - Avera Pharmaceuticals, Inc., a privately held pharmaceutical development company foc...
7.GreenHills Ventures   (36%):
Investors: Login | Businesses: Submit Plan GreenHills Ventures, LLC., combines extensive advisory experience with strategic initiatives. We focus on providing strong fundamentals to facilitate sound business execution. GreenHills Ventures, LLC., has developed an extensive network of Fortune 1000 co...
8.Leonard Green&Partners - Limited Partners   (19%):
Limited Partners The Limited Partners page is a secured page for the exclusive use by investors/limited partners in the Green Equity Investors Funds. Investors/limited partners can log in and review, download and print partnership financial reports. To begin, choose your fund: Green Equity Investors...
9.CM Equity Partners | Employment   (18%):
CM Equity Partners, L.P., a New York private equity firm with approximately $200 million of equity capital under management for middle-market leverage buyouts, is currently seeking ... No positions available at this time...
10.CM Equity Partners | Company Investments | CM Investors   (17%):
Team Profiles Business Advisory Group Carl Marks & Co. Value Creation Management Success Criteria Evaluation Financing CM Investors CM Equity Partners, L.P. CM Equity Partners II, L.P. Limited Partners Venture Partners CEOs The CMEP partners made these investments between 1993 and 1996 with the fin...
11.CM Equity Partners | Company Investments | CM Equity Partners II, L.P.   (15%):
Team Profiles Business Advisory Group Carl Marks & Co. Value Creation Management Success Criteria Evaluation Financing CM Investors CM Equity Partners, L.P. CM Equity Partners II, L.P. Limited Partners Venture Partners CEOs Raised in 2001/2002, this fund is approximately 60% invested and provides s...
12.Charlesbank Capital Partners   (14%):
Charlesbank Capital Partners is a leading private equity firm with more than $1.5 billion in assets. Focused on the middle market, we partner with strong management teams to acquire and build fundamentally strong businesses.
13.Charlesbank Capital Partners   (14%):
Charlesbank Capital Partners is a leading private equity firm with more than $1.5 billion in assets. Focused on the middle market, we partner with strong management teams to acquire and build fundamentally strong businesses.
14.Our Limited Partners   (14%):
About Brera Our People Our Investments Our Limited Partners Fund Information News Contact Us Print Our Site 3M ABB Anlagestiftung-Private Equity World 1 Audese Investments LLC Banc One Capital Corporation Bank of America Capital Corporation Bayer Corporation Beekman Vista, Inc. BT Investment Partner...
15.Baring Latin America Partners   (13%):
Baring Latin America Partners México DF. São Paulo. New York Portfolio Baring Latin America Partners manages three private equity funds with total committed capital of approximately $230 million: The Baring Mexico Private Equity Fund , the Baring Latin America Private Equity Fund and ...
16.Private Equity and ESOP Capital Funds - Churchill Capital   (13%):
CONTACT US | INVESTOR LOGIN | SITEMAP © 2003-2004 Churchill Capital Churchill Equity and ESOP Capital Partners II (Churchill Equity Partners) , a $242 million fund closed in 2000, provides transaction structure flexibility in the form of control or minority equity investments in middle market c...
17.Adams Street Partners   (13%):
U.S. Private Equity Partnership Investment Strategy and Overview of U.S. Markets, Adams Street Partners, June 2005 Adams Street Extends Its Global Reach, January 2005 Battleground states -- A geographic guide to public disclosure developments across America . This article was first published in the ...
18.CM Equity Partners | Company Investments | CM Equity Partners, L.P.   (13%):
Team Profiles Business Advisory Group Carl Marks & Co. Value Creation Management Success Criteria Evaluation Financing CM Investors CM Equity Partners, L.P. CM Equity Partners II, L.P. Limited Partners Venture Partners CEOs Raised in 1997, this fund was fully invested within 18 months. Five platfor...
19.Eos Private Equity Professionals   (13%):
Matt Meehan Prior to joining Eos, Matt was a General Partner at Stolberg, Meehan & Scano, Inc. Matt was formerly a Partner in the private equity group of Weiss, Peck & Greer. Matt has a B.A. from Amherst and an MBA from the Wharton School, University of Pennsylvania. CREDIT OPPORTUNITIES | EQUITY S...
20.Eos Private Equity Professionals   (13%):
Steven M. Friedman Steve is a General Partner of Eos. Prior to co-founding Eos in 1994, he was a General Partner at Odyssey Partners L.P., which he joined in 1983. Steve and Mr. Young were the partners responsible for Odyssey's private equity business. Before joining Odyssey, Steve was a vice presi...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others